Archive: 7/08/2014

FDA lifts hold on experimental Ebola drug

Federal health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use against an unprecedented outbreak of the deadly virus in West Africa.

Orbactiv approved for drug-resistant skin infections

(HealthDay)—The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.

CPR app linked to LA County dispatch system

The Los Angeles County Fire Department has linked its dispatch system to a smartphone app that will notify CPR-trained citizens when someone nearby is having a cardiac arrest.

page 1 from 9